Adcock Ingram Holdings Ltd. is a pharmaceutical company, which engages in the manufacture, marketing, and distribution of healthcare products to both private and public sectors of the market. The company is headquartered in Midrand, Gauteng. The company went IPO on 2008-08-25. The firm manufactures, markets, and distributes a range of healthcare and consumer products, and is a supplier to the private sector. Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. The OTC segment focuses on brands sold predominantly in pharmacies. The Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. The Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances, which are managed on a central basis in Southern Africa.
Follow-Up Questions
Who is the CEO of Adcock Ingram Holdings Ltd?
Mr. Andrew Hall is the Chief Executive Officer of Adcock Ingram Holdings Ltd, joining the firm since 2007.
What is the price performance of AIHLF stock?
The current price of AIHLF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Adcock Ingram Holdings Ltd?
Adcock Ingram Holdings Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Adcock Ingram Holdings Ltd market cap?
Adcock Ingram Holdings Ltd's current market cap is $0
Is Adcock Ingram Holdings Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Adcock Ingram Holdings Ltd, including 0 strong buy, 0 buy, 4 hold, 3 sell, and 0 strong sell
